| Reference |
|---|
Hua R, Gu S, Jiang J. Connexin 43 Hemichannels Regulate Osteoblast to Osteocyte Differentiation. Front Cell Dev Biol. 2022;10:892229 pubmed publisher |
Zhang Y, Yang M, Zhang S, Yang Z, Zhu Y, Wang Y, et al. BHLHE40 promotes osteoclastogenesis and abnormal bone resorption via c-Fos/NFATc1. Cell Biosci. 2022;12:70 pubmed publisher |
Cai P, Yan S, Lu Y, Zhou X, Wang X, Wang M, et al. Carnosol inhibits osteoclastogenesis in vivo and in vitro by blocking the RANKL‑induced NF‑κB signaling pathway. Mol Med Rep. 2022;26: pubmed publisher |
Cui Z, Feng C, Chen J, Wang Y, Meng Q, Zhao S, et al. Network Pharmacology Deciphers the Action of Bioactive Polypeptide in Attenuating Inflammatory Osteolysis via the Suppression of Oxidative Stress and Restoration of Bone Remodeling Balance. Oxid Med Cell Longev. 2022;2022:4913534 pubmed publisher |
Ma Y, DI R, Zhao H, Song R, Zou H, Liu Z. P2X7 receptor knockdown suppresses osteoclast differentiation by inhibiting autophagy and Ca2+/calcineurin signaling. Mol Med Rep. 2022;25: pubmed publisher |
Yang C, Tao H, Zhang H, Xia Y, Bai J, Ge G, et al. TET2 regulates osteoclastogenesis by modulating autophagy in OVX-induced bone loss. Autophagy. 2022;:1-13 pubmed publisher |
Kim J, Yang Y, Xie J, Lee O, Kim J, Hong J, et al. Regulation of sclerostin by the SIRT1 stabilization pathway in osteocytes. Cell Death Differ. 2022;: pubmed publisher |
Mamun Or Rashid A, Lucy T, Yagi M, Yonei Y. Inhibitory Effects of Astaxanthin on CML-HSA-Induced Inflammatory and RANKL-Induced Osteoclastogenic Gene Expression in RAW 264.7 Cells. Biomedicines. 2021;10: pubmed publisher |
Gu J, Zhang X, Zhang C, Li Y, Bian J, Liu X, et al. Galectin-3 Contributes to the Inhibitory Effect of lα,25-(OH)2D3 on Osteoclastogenesis. Int J Mol Sci. 2021;22: pubmed publisher |
Zhou S, Dai Q, Huang X, Jin A, Yang Y, Gong X, et al. STAT3 is critical for skeletal development and bone homeostasis by regulating osteogenesis. Nat Commun. 2021;12:6891 pubmed publisher |
Zhang Y, Zhang S, Wang Y, Yang Z, Chen Z, Wen N, et al. ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk-JNK through DOK3. Oxid Med Cell Longev. 2021;2021:2896674 pubmed publisher |
Liu Z, Wang H, Hou Y, Yang Y, Jia J, Wu J, et al. CNC-bZIP protein NFE2L1 regulates osteoclast differentiation in antioxidant-dependent and independent manners. Redox Biol. 2021;48:102180 pubmed publisher |
Nilsson K, Henning P, El Shahawy M, Nethander M, Andersen T, Ejersted C, et al. RSPO3 is important for trabecular bone and fracture risk in mice and humans. Nat Commun. 2021;12:4923 pubmed publisher |
Fang C, Guo J, Wang Y, Li X, Zhang H, Cui J, et al. Diterbutyl phthalate attenuates osteoarthritis in ACLT mice via suppressing ERK/c-fos/NFATc1 pathway, and subsequently inhibiting subchondral osteoclast fusion. Acta Pharmacol Sin. 2021;: pubmed publisher |
Wang K, Donnelly C, Jiang C, Liao Y, Luo X, Tao X, et al. STING suppresses bone cancer pain via immune and neuronal modulation. Nat Commun. 2021;12:4558 pubmed publisher |
Chen H, Shen G, Shang Q, Zhang P, Yu D, Yu X, et al. Plastrum testudinis extract suppresses osteoclast differentiation via the NF-κB signaling pathway and ameliorates senile osteoporosis. J Ethnopharmacol. 2021;276:114195 pubmed publisher |
Xue P, Hu X, Chang E, Wang L, Chen M, Wu T, et al. Deficiency of optineurin enhances osteoclast differentiation by attenuating the NRF2-mediated antioxidant response. Exp Mol Med. 2021;53:667-680 pubmed publisher |
Wei H, Xu Y, Wang Y, Xu L, Mo C, Li L, et al. Identification of Fibroblast Activation Protein as an Osteogenic Suppressor and Anti-osteoporosis Drug Target. Cell Rep. 2020;33:108252 pubmed publisher |
Chen Y, Wang Y, Tang R, Yang J, Dou C, Dong Y, et al. Dendritic cells-derived interferon-λ1 ameliorated inflammatory bone destruction through inhibiting osteoclastogenesis. Cell Death Dis. 2020;11:414 pubmed publisher |
Wang K, Gu Y, Liao Y, Bang S, Donnelly C, Chen O, et al. PD-1 blockade inhibits osteoclast formation and murine bone cancer pain. J Clin Invest. 2020;130:3603-3620 pubmed publisher |
Kim J, Yang Y, Park K, Ge X, Xu R, Li N, et al. A RUNX2 stabilization pathway mediates physiologic and pathologic bone formation. Nat Commun. 2020;11:2289 pubmed publisher |
Du T, Yan Z, Zhu S, Chen G, Wang L, Ye Z, et al. QKI deficiency leads to osteoporosis by promoting RANKL-induced osteoclastogenesis and disrupting bone metabolism. Cell Death Dis. 2020;11:330 pubmed publisher |
Kim S, Jeong Y, Jeong S, Park M, Go H, Kim M, et al. Neural regulation of energy and bone homeostasis by the synaptic adhesion molecule Calsyntenin-3. Exp Mol Med. 2020;52:793-803 pubmed publisher |
Kang I, Jang J, Kim C. Opposing roles of hematopoietic-specific small GTPase Rac2 and the guanine nucleotide exchange factor Vav1 in osteoclast differentiation. Sci Rep. 2020;10:7024 pubmed publisher |
Lei W, Duan R, Li J, Liu X, Huston A, Boyce B, et al. The IAP Antagonist SM-164 Eliminates Triple-Negative Breast Cancer Metastasis to Bone and Lung in Mice. Sci Rep. 2020;10:7004 pubmed publisher |
Kiyohara S, Sakai N, Handa K, Yamakawa T, Ishikawa K, Chatani M, et al. Effects of N-methyl-d-aspartate receptor antagonist MK-801 (dizocilpine) on bone homeostasis in mice. J Oral Biosci. 2020;62:131-138 pubmed publisher |
Zhang Y, Yang K, Yang J, Lao Y, Deng L, Deng G, et al. SENP3 Suppresses Osteoclastogenesis by De-conjugating SUMO2/3 from IRF8 in Bone Marrow-Derived Monocytes. Cell Rep. 2020;30:1951-1963.e4 pubmed publisher |
Brunner J, Vulliard L, Hofmann M, Kieler M, Lercher A, Vogel A, et al. Environmental arginine controls multinuclear giant cell metabolism and formation. Nat Commun. 2020;11:431 pubmed publisher |
Pore S, Hahm E, Kim S, Singh K, Nyiranshuti L, Latoche J, et al. A Novel Sulforaphane-Regulated Gene Network in Suppression of Breast Cancer-Induced Osteolytic Bone Resorption. Mol Cancer Ther. 2020;19:420-431 pubmed publisher |
Shang N, Wu J. Egg White Ovotransferrin Attenuates RANKL-Induced Osteoclastogenesis and Bone Resorption. Nutrients. 2019;11: pubmed publisher |
Li L, Ameri A, Wang S, Jansson K, Casey O, Yang Q, et al. EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene. 2019;38:6241-6255 pubmed publisher |
Wong S, Huang B, Hu X, Ho Kim E, Kolb J, Padilla R, et al. Global deletion of Optineurin results in altered type I IFN signaling and abnormal bone remodeling in a model of Paget's disease. Cell Death Differ. 2019;: pubmed publisher |
Bergsma A, Ganguly S, Wiegand M, Dick D, Williams B, Miranti C. Regulation of cytoskeleton and adhesion signaling in osteoclasts by tetraspanin CD82. Bone Rep. 2019;10:100196 pubmed publisher |
Muschter D, Beiderbeck A, Späth T, Kirschneck C, Schröder A, Grassel S. Sensory Neuropeptides and their Receptors Participate in Mechano-Regulation of Murine Macrophages. Int J Mol Sci. 2019;20: pubmed publisher |
Jones J, Sinder B, Paige D, Soki F, Koh A, Thiele S, et al. Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis. Neoplasia. 2019;21:172-184 pubmed publisher |
Wee N, Sinder B, Novak S, Wang X, Stoddard C, Matthews B, et al. Skeletal phenotype of the neuropeptide Y knockout mouse. Neuropeptides. 2019;73:78-88 pubmed publisher |
Lee K, Park K, Hwang J, Lee M, Yoon D, Ryu H, et al. Inhibition of STAT5A promotes osteogenesis by DLX5 regulation. Cell Death Dis. 2018;9:1136 pubmed publisher |
Wang H, Wang P, Chen Y, Zhang Y. Bevacizumab or fibronectin gene editing inhibits the osteoclastogenic effects of fibroblasts derived from human radicular cysts. Acta Pharmacol Sin. 2019;40:949-956 pubmed publisher |
Mödinger Y, Rapp A, Pázmándi J, Vikman A, Holzmann K, Haffner Luntzer M, et al. C5aR1 interacts with TLR2 in osteoblasts and stimulates the osteoclast-inducing chemokine CXCL10. J Cell Mol Med. 2018;22:6002-6014 pubmed publisher |
Ma G, Lee S, Park K, Park J, Son S, Jung M, et al. Artemisinin-Daumone Hybrid Inhibits Cancer Cell-Mediated Osteolysis by Targeting Cancer Cells and Osteoclasts. Cell Physiol Biochem. 2018;49:1460-1475 pubmed publisher |
Ubellacker J, Baryawno N, Severe N, Decristo M, Sceneay J, Hutchinson J, et al. Modulating Bone Marrow Hematopoietic Lineage Potential to Prevent Bone Metastasis in Breast Cancer. Cancer Res. 2018;78:5300-5314 pubmed publisher |
Niedermair T, Schirner S, Seebröker R, Straub R, Grassel S. Substance P modulates bone remodeling properties of murine osteoblasts and osteoclasts. Sci Rep. 2018;8:9199 pubmed publisher |
Yu Z, Surface L, Park C, Horlbeck M, Wyant G, Abu Remaileh M, et al. Identification of a transporter complex responsible for the cytosolic entry of nitrogen-containing bisphosphonates. elife. 2018;7: pubmed publisher |
Grcevic D, Sironi M, Valentino S, Deban L, Cvija H, Inforzato A, et al. The Long Pentraxin 3 Plays a Role in Bone Turnover and Repair. Front Immunol. 2018;9:417 pubmed publisher |
Ishii T, Ruiz Torruella M, Ikeda A, Shindo S, Movila A, Mawardi H, et al. OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9. FASEB J. 2018;32:4016-4030 pubmed publisher |
Jia Z, Li H, Liang Y, Potempa L, Ji S, Wu Y. Monomeric C-Reactive Protein Binds and Neutralizes Receptor Activator of NF-κB Ligand-Induced Osteoclast Differentiation. Front Immunol. 2018;9:234 pubmed publisher |
Mediero A, Wilder T, Shah L, Cronstein B. Adenosine A2A receptor (A2AR) stimulation modulates expression of semaphorins 4D and 3A, regulators of bone homeostasis. FASEB J. 2018;32:3487-3501 pubmed publisher |
Ye Q, Li G, Liu S, Guan Y, Li Y, Li J, et al. Targeted disruption of adenosine kinase in myeloid monocyte cells increases osteoclastogenesis and bone resorption in mice. Int J Mol Med. 2018;41:2177-2184 pubmed publisher |
Kim C, Shin S, Kim B, Kim C, Kim J, Kang H, et al. The Effects of Kaempferol-Inhibited Autophagy on Osteoclast Formation. Int J Mol Sci. 2018;19: pubmed publisher |
Quach D, Collins F, Parameswaran N, McCabe L, Britton R. Microbiota Reconstitution Does Not Cause Bone Loss in Germ-Free Mice. mSphere. 2018;3: pubmed publisher |
Wei Y, Zhan Y, Chen P, Liu Z, Zhang H, Liu D, et al. Heterologous expression, purification and function of the extracellular domain of human RANK. BMC Biotechnol. 2017;17:87 pubmed publisher |
Park H, Son Y, Lee S, Rho G, Kang Y, Park B, et al. Effects of Osteogenic-Conditioned Medium from Human Periosteum-Derived Cells on Osteoclast Differentiation. Int J Med Sci. 2017;14:1389-1401 pubmed publisher |
Kram V, Kilts T, Bhattacharyya N, Li L, Young M. Small leucine rich proteoglycans, a novel link to osteoclastogenesis. Sci Rep. 2017;7:12627 pubmed publisher |
Stattin E, Henning P, Klar J, McDermott E, Stecksen Blicks C, Sandström P, et al. SNX10 gene mutation leading to osteopetrosis with dysfunctional osteoclasts. Sci Rep. 2017;7:3012 pubmed publisher |
Strålberg F, Kassem A, Kasprzykowski F, Abrahamson M, Grubb A, Lindholm C, et al. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors. J Leukoc Biol. 2017;101:1233-1243 pubmed publisher |
Ramos Junior E, Leite G, Carmo Silva C, Taira T, Neves K, Colón D, et al. Adipokine Chemerin Bridges Metabolic Dyslipidemia and Alveolar Bone Loss in Mice. J Bone Miner Res. 2017;32:974-984 pubmed publisher |
Batsir S, Geiger B, Kam Z. Dynamics of the sealing zone in cultured osteoclasts. Cytoskeleton (Hoboken). 2017;74:72-81 pubmed publisher |
Karlsson T, Lundholm M, Widmark A, Persson E. Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and Differentiation. PLoS ONE. 2016;11:e0166284 pubmed publisher |
Khor E, Fanshawe B, Qi Y, Zolotukhin S, Kulkarni R, Enriquez R, et al. Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome. PLoS ONE. 2016;11:e0148155 pubmed publisher |
Beier E, Sheu T, Dang D, Holz J, Ubayawardena R, Babij P, et al. Heavy Metal Ion Regulation of Gene Expression: MECHANISMS BY WHICH LEAD INHIBITS OSTEOBLASTIC BONE-FORMING ACTIVITY THROUGH MODULATION OF THE Wnt/β-CATENIN SIGNALING PATHWAY. J Biol Chem. 2015;290:18216-26 pubmed publisher |
Fowler T, Kamalakar A, Akel N, Kurten R, Suva L, Gaddy D. Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures. J Cell Sci. 2015;128:683-94 pubmed publisher |
Mediero A, Ramkhelawon B, Perez Aso M, Moore K, Cronstein B. Netrin-1 is a critical autocrine/paracrine factor for osteoclast differentiation. J Bone Miner Res. 2015;30:837-54 pubmed publisher |
Nickel N, Godau J, Willie B, Duda G, Schwarzer R, Cirovic B, et al. Notch pathway inhibition controls myeloma bone disease in the murine MOPC315.BM model. Blood Cancer J. 2014;4:e217 pubmed publisher |
Zhang H, Hilton M, Anolik J, Welle S, Zhao C, Yao Z, et al. NOTCH inhibits osteoblast formation in inflammatory arthritis via noncanonical NF-κB. J Clin Invest. 2014;124:3200-14 pubmed publisher |
Tiwari M, Sharma L, Vanegas D, Callaway D, Bai Y, Lechleiter J, et al. A nonapoptotic role for CASP2/caspase 2: modulation of autophagy. Autophagy. 2014;10:1054-70 pubmed publisher |
Xiu Y, Xu H, Zhao C, Li J, Morita Y, Yao Z, et al. Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. J Clin Invest. 2014;124:297-310 pubmed publisher |
Stalvey M, Clines K, Havasi V, McKibbin C, Dunn L, Chung W, et al. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease. PLoS ONE. 2013;8:e80098 pubmed publisher |
Sun Q, Sammut B, Wang F, Kurihara N, Windle J, Roodman G, et al. TBK1 mediates critical effects of measles virus nucleocapsid protein (MVNP) on pagetic osteoclast formation. J Bone Miner Res. 2014;29:90-102 pubmed publisher |
Muruganandan S, Dranse H, Rourke J, McMullen N, Sinal C. Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis. Stem Cells. 2013;31:2172-82 pubmed publisher |
Fujiwara T, Fukushi J, Yamamoto S, Matsumoto Y, Setsu N, Oda Y, et al. Macrophage infiltration predicts a poor prognosis for human ewing sarcoma. Am J Pathol. 2011;179:1157-70 pubmed publisher |
Kulkarni R, Bakker A, Everts V, Klein Nulend J. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE. Calcif Tissue Int. 2010;87:461-8 pubmed publisher |
Binder N, Niederreiter B, Hoffmann O, Stange R, Pap T, Stulnig T, et al. Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. Nat Med. 2009;15:417-24 pubmed publisher |
Johansson M, de Vries T, Schoenmaker T, Ehinger M, Brun A, Fasth A, et al. Hematopoietic stem cell-targeted neonatal gene therapy reverses lethally progressive osteopetrosis in oc/oc mice. Blood. 2007;109:5178-85 pubmed |
de Vries T, Schoenmaker T, Wattanaroonwong N, van den Hoonaard M, Nieuwenhuijse A, Beertsen W, et al. Gingival fibroblasts are better at inhibiting osteoclast formation than periodontal ligament fibroblasts. J Cell Biochem. 2006;98:370-82 pubmed |
Liao T, Yurgelun M, Chang S, Zhang H, Murakami K, Blaine T, et al. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J Orthop Res. 2005;23:203-9 pubmed |
